Interstitial pulmonary edema following bromocarbamide intoxication.

Area of Science:

• Pharmacology
• Pathology
• Toxicology

Background:

• Bromocarbamides are sedative drugs with potential for fatal respiratory failure.
• Pulmonary edema is a serious complication of bromocarbamide intoxication.
• The exact mechanism, hemodynamic or endothelial, causing pulmonary edema is unclear.

Purpose of the Study:

• To investigate the role of hemodynamic factors versus endothelial permeability in bromocarbamide-induced pulmonary edema.
• To elucidate the ultrastructural changes in pulmonary edema following bromocarbamide administration.

Main Methods:

• Animal experiments using rabbits orally administered bromocarbamides.
• Observation of pulmonary fine structural changes at 60, 90, and 120 minutes.
• Hemodynamic measurements, including pulmonary arterial pressure and vascular resistance, in artificially respirated animals.
• Assessment of colloidal carbon and exogenous peroxidase uptake to evaluate vascular permeability.

Main Results:

• Ultrastructural analysis revealed blebs between capillary endothelium and alveolar epithelium, and interstitial edema of vessel walls.
• Bleb contents were less electron-dense than capillary blood, and colloidal carbon did not penetrate these areas.
• Increased uptake of exogenous peroxidase in pinocytotic vesicles indicated increased endothelial transport.
• Hemodynamic parameters remained within normal ranges in artificially respirated animals, ruling out anoxia and significant hemodynamic changes as primary causes.
• Bromocarbamide intoxication primarily increases endothelial permeability via enhanced cytoplasmic transport.

Conclusions:

• Hemodynamic factors are unlikely to be the primary cause of bromocarbamide-induced pulmonary edema.
• Increased endothelial permeability, driven by enhanced cytoplasmic transport, is the chief early factor.
• Treatment strategies should prioritize cautious fluid management in patients with bromocarbamide intoxication to prevent fluid overload.